Already 2,462 people have seen this company's branding and they are being followed by 2 Storybook user.In average the company has been rated 4.5 points but has not been commented.

's activity report 2022

Pharmacy Wholesale OÜ started active economic activity in 2015. The main activity of the company is the wholesale of medicines.

The turnover in 2022 was 6.4 million euros, with a profit of 0.47 million euros. The company continued to create potential customer contacts both in Estonia and internationally. During the reporting year, the company's customer base consisted mainly of wholesale drug dealers and hospitals operating in Estonia. Pharmacy Wholesale OÜ regularly participates in public procurements at both hospital and state level.

In 2022, the impact of COVID-19 was still felt in both the healthcare and pharmaceutical sectors. The company was able to adapt in a changing environment and continue to be a reliable partner for both customers and suppliers.

The company's business is not seasonal and the company's activities do not have significant environmental and social impacts. During the financial year and the reporting period, the company has been slightly affected by risks related to changes in exchange rates and interest rates.

The company employed an average of 7 full-time employees during the past financial year and the wage fund was 270,929 euros, of which board member fees accounted for 12,628 euros.

Company's financial indicators and ratios (in euros) 2022 2021

Sales revenue 6,359,323 4,615,905

Net profit 472,891 364,886

Assets 3,307,349 2,363,917

Net profit margin, % 7.4 7.9 Net profit/Sales revenue*100

Asset productivity, % 14.3 15.4 Net profit/ Assets*100

General liquidity ratio 2.5 2.6 Current assets/Short-term liabilities

Return on equity % 24.4 24.6 Net profit/Equity*100

In the following financial year, 2023, the plan is to continue in the same field of activity and the growth forecast for turnover is 5-10 %. The board places more emphasis on expanding the range of medicines. We continue to forecast a more challenging business environment in 2023.

In 2023, we will actively ensure the supply of existing products. We have also set a goal to bring innovative medicines to the market, which would allow healthcare institutions to offer a more diverse range of medical services to Estonian patients. To achieve these goals, we consider it important to maintain the existing network of suppliers in the coming years.